My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression.

    Le TK, Able SL, Lage MJ.

    Cost Eff Resour Alloc. 2006 Oct 23;4:18.PMID: 17059602 [PubMed]Related articlesFree article

    2.

    A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients.

    Boulanger L, Zhao Y, Bao Y, Russell MW.

    BMC Health Serv Res. 2009 Jun 30;9:111.PMID: 19566952 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The burden of illness of hypertension and comorbid diabetes.

    Eaddy MT, Shah M, Lunacsek O, Stanford RH.

    Curr Med Res Opin. 2008 Sep;24(9):2501-7. Epub 2008 Jul 29.PMID: 18671895 [PubMed - indexed for MEDLINE]Related articles

    4.
    5.

    Impact of antidepressant drug adherence on comorbid medication use and resource utilization.

    Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM.

    Arch Intern Med. 2005 Nov 28;165(21):2497-503.PMID: 16314547 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy.

    Zhao Y, Ye W, Boye KS, Holcombe JH, Hall JA, Swindle R.

    J Diabetes Complications. 2010 Jan-Feb;24(1):9-19. Epub 2008 Oct 18.PMID: 18930413 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

    Khandker RK, Kruzikas DT, McLaughlin TP.

    J Manag Care Pharm. 2008 Jun;14(5):426-41.PMID: 18597572 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

    Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

    Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.PMID: 17669232 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Comorbidity and related costs as a burden in the treatment of outpatients with depressive disorders in a primary care setting]

    Sicras Mainar A, Navarro Artieda R, Rejas Gutiérrez J, Blanca Tamayo M, Serrat Tarrés J, Llopart López JR.

    Farm Hosp. 2007 Mar-Apr;31(2):101-5. Spanish. PMID: 17590118 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Comparing clinical and economic characteristics between commercially-insured patients with diabetic neuropathy and demographically-matched diabetic controls.

    Zhao Y, Ye W, Le TK, Boye KS, Holcombe JH, Swindle R.

    Curr Med Res Opin. 2009 Mar;25(3):585-97.PMID: 19232033 [PubMed - in process]Related articles

    11.

    Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.

    Boulanger L, Zhao Y, Foster TS, Fraser K, Bledsoe SL, Russell MW.

    Curr Med Res Opin. 2009 Jul;25(7):1763-73.PMID: 19505204 [PubMed - indexed for MEDLINE]Related articles

    12.

    Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.

    Laliberté F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, Piech CT, Lefebvre P.

    J Manag Care Pharm. 2009 May;15(4):312-22.PMID: 19422271 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

    Clin Ther. 2007;29 Spec No:1294-305.PMID: 18046929 [PubMed - indexed for MEDLINE]Related articles

    14.

    Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

    Clin Ther. 2007 Jun;29(6 Pt 1):1294-305.PMID: 18036391 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.

    Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

    Clin Ther. 2007 Jun;29(6 Pt 1):1306-15.PMID: 18036392 [PubMed - indexed for MEDLINE]Related articles

    16.

    Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.

    van der Linden MW, Plat AW, Erkens JA, Emneus M, Herings RM.

    Value Health. 2009 Sep;12(6):909-14. Epub 2009 Mar 11.PMID: 19508664 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus.

    Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

    Clin Ther. 2007;29 Spec No:1306-15.PMID: 18046930 [PubMed - indexed for MEDLINE]Related articles

    18.

    Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

    Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

    J Manag Care Pharm. 2008 Mar;14(2):176-85.PMID: 18331119 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cost of Type 2 Diabetes mellitus in Hong Kong Chinese.

    Chan BS, Tsang MW, Lee VW, Lee KK.

    Int J Clin Pharmacol Ther. 2007 Aug;45(8):455-68.PMID: 17725179 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.

    Movva S, Alluri RV, Komandur S, Vattam K, Eppa K, Mukkavali KK, Mubigonda S, Saharia S, Shastry JC, Hasan Q.

    J Diabetes Complications. 2007 Jul-Aug;21(4):237-41.PMID: 17616353 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk